Safety, quality & education

Cardiovascular Drug Administration Errors During Neuraxial Anesthesia or Analgesia—A Narrative Review

J Cardiothorac Vasc AnesthPublished Narrative review of case reports

Study context

Population
Patients receiving accidental neuraxial cardiovascular (CV) medication during spinal or epidural anesthesia or analgesia, reports 1972–202227 publications · 33 errors
Outcome
Neuraxial CV drug administration errors and associated clinical consequences
Methodological detailshuman factor analysis classification system (HFACS)
  • Human factor analysis classification system (HFACS)

Main finding

As reported in the abstract

CV drugs involved
10
Errors via epidural route
17 of 33
Digoxin
9 patients
Ephedrine
6
Metaraminol
4
Labetalol
4
Dopamine
3
Bolus injections only
30 out of 32

Secondary outcomes

Causes and contributory factors (HFACS)

Poor organizational climate, inadequate supervision of junior doctors, deficiencies in neuraxial task processes, incorrect visual perception of objects

Safety

Harm after intrathecal digoxin

Intrathecal digoxin associated with paraplegia and encephalopathy
8 patients
Pregnant women scheduled for elective cesarean delivery with permanent lower limb neurologic deficits
4

Harm after epidural inotropes and vasopressors

Reversible systemic hemodynamic changes predominant

Original publication

Cardiovascular Drug Administration Errors During Neuraxial Anesthesia or Analgesia—A Narrative Review. J Cardiothorac Vasc Anesth. Published 26 October 2022. doi:10.1053/j.jvca.2022.10.016

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.